Tenvir (Viread)300MG – 30 tablet

$66.29

Each Tenvir contains 300 mg Tenofovir Disoproxil Fumarate 30 tablets used in the treatment of HIV and to treat hepatitis B infection.

ATC Classification: J05AF07
Active Ingrediant: Tenofovir Disoproxil Fumarate
Generic Name: Tenvir
Manufacturer: Cipla Limited
Strength: 300MG
Dosage Type: Tablet
Packaging Type: Bottle in Box
Contains: 30 Tab

What is this drug used for?

• It is used to treat HIV infection.

• It is used to treat hepatitis B infection.

Frequently reported side effects of this drug

• Headache

• Dizziness

• Nausea

• Vomiting

• Diarrhea

• Pain

• Abdominal pain

• Trouble sleeping

• Anxiety

• Loss of strength and energy

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• Liver problems like dark urine, fatigue, lack of appetite, nausea, abdominal pain, light-colored stools, vomiting, or yellow skin.

• Kidney problems like unable to pass urine, blood in the urine, change in amount of urine passed, or weight gain.

• Lactic acidosis like fast breathing, fast heartbeat, abnormal heartbeat, vomiting, fatigue, shortness of breath, severe loss of strength and energy, severe dizziness, feeling cold, or muscle pain or cramps.

• Depression

• Bone pain

• Muscle pain

• Muscle weakness

• Painful extremities

• Burning or numbness feeling

• Infection

• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

Note: This is not a comprehensive list of all side effects. Talk to your doctor if you have questions.

 

Pronunciation

(ten OF oh vir dye soe PROX il FUE ma rate)

Medication Safety Issues

High alert medication:

This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes that have a heightened risk of causing significant patient harm when used in error.

 

Storage and Stability

Store at 25°C (77°F); excursions are permitted between 15°C and 30°C (59°F and 86°F). Dispense only in original container.

 

Adverse Reactions

Includes data from both treatment-naive and treatment-experienced HIV patients and in chronic hepatitis B.

Cardiovascular: Chest pain

Central nervous system: Anxiety, depression, dizziness, fatigue, headache, insomnia, pain, peripheral neuropathy

Dermatologic: Diaphoresis, pruritus, skin rash (includes maculopapular, pustular, or vesiculobullous rash; pruritus; or urticaria)

Endocrine & metabolic: Glycosuria, hypercholesterolemia, hyperglycemia, increased serum triglycerides, lipodystrophy, weight loss

Gastrointestinal: Abdominal pain, anorexia, diarrhea, dyspepsia, flatulence, increased serum amylase, nausea, vomiting

Genitourinary: Hematuria

Hematologic & oncologic: Neutropenia

Hepatic: Increased serum alkaline phosphatase, increased serum ALT, increased serum AST, increased serum transaminases

Neuromuscular & skeletal: Arthralgia, back pain, decreased bone mineral density, increased creatine phosphokinase, myalgia, weakness

Renal: Increased serum creatinine, renal failure

Respiratory: Nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection

Miscellaneous: Fever

Rare but important or life-threatening: Angioedema, exacerbation of hepatitis B (following discontinuation), Fanconi’s syndrome, hepatitis, hypersensitivity reaction, hypokalemia, hypophosphatemia, immune reconstitution syndrome, increased gamma-glutamyl transferase, interstitial nephritis, lactic acidosis, myopathy, nephrogenic diabetes insipidus, nephrotoxicity, osteomalacia, pancreatitis, polyuria, proteinuria, proximal tubular nephropathy, renal insufficiency, renal tubular necrosis, rhabdomyolysis, severe hepatomegaly with steatosis

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type

Shipping From

Brand

Cipla

Reviews

There are no reviews yet.

Be the first to review “Tenvir (Viread)300MG – 30 tablet”

Your email address will not be published. Required fields are marked *